Cargando…
Impact of SARS-CoV-2 delta variant (B.1.617.2) in surging second wave of COVID-19 and efficacy of vaccines in tackling the ongoing pandemic
Autores principales: | Tareq, Abu Montakim, Emran, Talha Bin, Dhama, Kuldeep, Dhawan, Manish, Tallei, Trina Ekawati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425453/ https://www.ncbi.nlm.nih.gov/pubmed/34473593 http://dx.doi.org/10.1080/21645515.2021.1963601 |
Ejemplares similares
-
Increasing severity of COVID-19 in pregnancy with Delta (B.1.617.2) variant surge
por: Adhikari, Emily H., et al.
Publicado: (2022) -
Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions
por: Dhawan, Manish, et al.
Publicado: (2022) -
Mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum
por: Devnath, Popy, et al.
Publicado: (2021) -
Analysis of the Delta Variant B.1.617.2 COVID-19
por: Shiehzadegan, Shayan, et al.
Publicado: (2021) -
Bromelain a Potential Bioactive Compound: A Comprehensive Overview from a Pharmacological Perspective
por: Chakraborty, Arka Jyoti, et al.
Publicado: (2021)